Harold L. Moses

2000 -

scolarité: Université Vanderbilt, National Institutes of Health, Berea College, University of the Cumberlands

distinction reçue: membre de l'AAAS, AACR Award for Lifetime Achievement in Cancer Research

Harold L. Moses is the Ingram Professor of Cancer Research, Professor of Cancer Biology, Medicine and Pathology, and director emeritus at the Vanderbilt-Ingram Cancer Center. He was president of the American Association for Cancer Research in 1991. Source : Wikipedia (en)

Séries

Il n'y a rien à voir ici

Créer une nouvelle série

Œuvres

Il n'y a rien à voir ici

Créer une nouvelle œuvre

Articles 174

Date

Titre

Auteur·ices

2020-04-20

Myeloid cell-derived TGF-beta signaling regulates ECM deposition in mammary carcinoma via adenosine-dependent mechanisms

Andries Zijlstra, Harold L. Moses
2019-01-18

Blocking CXCLs-CXCR2 axis in tumor-stromal interactions contributes to survival in a mouse model of pancreatic ductal adenocarcinoma through reduced cell invasion/migration and a shift of immune-inflammatory microenvironment

Kazuhiko Koike, Harold L. Moses
2019-12-08

Challenges and Opportunities to Updating Prescribing Information for Longstanding Oncology Drugs

Erin P Balogh, Harold L. Moses
2017-01-06

TGF-β, Bone Morphogenetic Protein, and Activin Signaling and the Tumor Microenvironment

Harold L. Moses
2017-03-01

Inhibition of TGF-β with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression

Harold L. Moses
2017-02-11

Functional KRAS mutations and a potential role for PI3K/AKT activation in Wilms tumors

William Pao, Harold L. Moses
2017-08-03

Development of Aggressive Pancreatic Ductal Adenocarcinomas Depends on Granulocyte Colony Stimulating Factor Secretion in Carcinoma Cells

Valerie M Weaver, Harold L. Moses
2017-07-10

Pharmacologic Inhibition of β-Catenin With Pyrvinium Inhibits Murine and Human Models of Wilms Tumor.

Harold L. Moses
2016-07-01

The Discovery and Early Days of TGF-β: A Historical Perspective

Harold L. Moses, Anita Roberts
2016-04-18

Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression

Valeria Poli, Valerie M Weaver, Harold L. Moses, Christine A Iacobuzio-Donahue, Eric Collisson
2016-06-16

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

Brian D. Lehmann, Mónica Valeria Estrada, Jennifer A. Pietenpol, Harold L. Moses
2016-11-04

TβRIII Expression in Human Breast Cancer Stroma and the Role of Soluble TβRIII in Breast Cancer Associated Fibroblasts

Harold L. Moses
2016-01-27

Fibroblast-Mediated Collagen Remodeling Within the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by BrafV600E and Pten Loss

Harold L. Moses
2016-03-09

The impact of bone morphogenetic protein 4 (BMP4) on breast cancer metastasis in a mouse xenograft model

Anne Kallioniemi, Harold L. Moses
2016-04-11

Biomarker Tests for Molecularly Targeted Therapies: Laying the Foundation and Fulfilling the Dream

Harold L. Moses
2016-12-21

PI3K Inhibition Reduces Mammary Tumor Growth and Facilitates Antitumor Immunity and Anti-PD1 Responses.

Mark R. Boothby, Harold L. Moses, Gregory Daniel Ayers, Ann Richmond
2016-06-01

Biomarker Tests for Molecularly Targeted Therapies--The Key to Unlocking Precision Medicine.

Harold L. Moses
2015-01-28

TGFβ signaling in myeloid cells regulates mammary carcinoma cell invasion through fibroblast interactions

Aubie Shaw, Harold L. Moses
2015-01-22

Age- and pregnancy-associated DNA methylation changes in mammary epithelial cells

Kendell Clement, Mary Helen Barcellos-Hoff, Harold L. Moses, Kornelia Polyak
2015-08-07

Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer

Nagaraj Nagathihalli, Harold L. Moses
2015-07-30

Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growth

Harold L. Moses
2015-06-10

Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis

Harold L. Moses
2015-04-28

A Murine Model of K-RAS and β-Catenin Induced Renal Tumors Expresses High Levels of E2F1 and Resembles Human Wilms Tumor

Harold L. Moses
2015-12-18

Bone morphogenetic protein signaling promotes tumorigenesis in a murine model of high-grade glioma

Harold L. Moses
2015-12

Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival

Chia-Chin Wu, James P. Allison, Julienne L. Carstens, Valerie M Weaver, Lynda Chin, Harold L. Moses, Anirban Maitra
2014-10-04

Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis

Harold L. Moses
2014-09-15

Role of TGF-β signaling in generation of CD39+CD73+ myeloid cells in tumors

Qinkun Zhang, Igor Feoktistov, Harold L. Moses
2014-07-01

Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer

J Scott Beeler, Brian D. Lehmann, Jennifer A. Pietenpol, Harold L. Moses
2014-01-02

ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to bone

Simon W. Hayward, Andries Zijlstra, Harold L. Moses, Alyssa R. Merkel
2014-05-22

Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival

Lynda Chin, James P. Allison, Julienne L. Carstens, Valerie M Weaver, Harold L. Moses, Anirban Maitra
2014-09-18

Concerted loss of TGFβ-mediated proliferation control and E-cadherin disrupts epithelial homeostasis and causes oral squamous cell carcinoma

Harold L. Moses
2014-08-23

BMPR2 loss in fibroblasts promotes mammary carcinoma metastasis via increased inflammation

Harold L. Moses

Humain - wd:Q47005604

Bienvenue sur Inventaire

la bibliothèque de vos ami⋅e⋅s et communautés